These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34893980)

  • 1. A systematic review of maternal TORCH serology as a screen for suspected fetal infection.
    Fitzpatrick D; Holmes NE; Hui L
    Prenat Diagn; 2022 Jan; 42(1):87-96. PubMed ID: 34893980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom.
    Abdel-Fattah SA; Bhat A; Illanes S; Bartha JL; Carrington D
    Prenat Diagn; 2005 Nov; 25(11):1028-31. PubMed ID: 16231309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Utility of Maternal TORCH Screening Due to Obstetrical Indications in Detecting Congenital Infections: A Retrospective Observational Study.
    Abu Shqara R; Or S; Abu Zraki A; Rizik J; Glikman D; Rechnitzer H; Lowenstein L; Frank Wolf M
    Pediatr Infect Dis J; 2024 Jan; 43(1):69-73. PubMed ID: 37725823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TORCH screening in polyhydramnios: an observational study.
    Fayyaz H; Rafi J
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1069-72. PubMed ID: 21923307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of maternal TORCH screening in fetal growth restriction: A retrospective two-centre study.
    Wade CA; Atkinson N; Holmes NE; Hui L
    Aust N Z J Obstet Gynaecol; 2024 Feb; ():. PubMed ID: 38380539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology and disease burden of congenital TORCH infections among hospitalized children in China: A national cross-sectional study.
    Zhang L; Wang X; Liu M; Feng G; Zeng Y; Wang R; Xie Z
    PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010861. PubMed ID: 36240247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction.
    Yamamoto R; Ishii K; Shimada M; Hayashi S; Hidaka N; Nakayama M; Mitsuda N
    J Obstet Gynaecol Res; 2013 Mar; 39(3):653-7. PubMed ID: 23107457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yield and costs of screening growth-retarded infants for torch infections.
    Khan NA; Kazzi SN
    Am J Perinatol; 2000; 17(3):131-5. PubMed ID: 11012137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of ToRCH infection and congenital malformations: A prospective study in China.
    Wang Y; Li S; Ma N; Zhang Q; Wang H; Cui J; Wang S
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():336-340. PubMed ID: 31382146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound indications for maternal STORCH testing in pregnancy.
    Voekt CA; Rinderknecht T; Hirsch HH; Blaich A; Hösli IM
    Swiss Med Wkly; 2017; 147():w14534. PubMed ID: 29185251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the relationship between the history of abnormal pregnancy and TORCH infection in pregnant woman].
    Cao Y; Qiu L; Zhang Q
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):517-20. PubMed ID: 11360633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stop, think SCORTCH: rethinking the traditional 'TORCH' screen in an era of re-emerging syphilis.
    Penner J; Hernstadt H; Burns JE; Randell P; Lyall H
    Arch Dis Child; 2021 Feb; 106(2):117-124. PubMed ID: 32586930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH) infections among women attending the antenatal care clinic, maternity hospital in Abha, Southwestern Saudi Arabia.
    Al-Hakami AM; Paul E; Al-Abed F; Alzoani AA; Shati AA; Assiri MI; Qasim AA; Riaz F; Moosa RA; Chandramoorthy HC
    Saudi Med J; 2020 Jul; 41(7):757-762. PubMed ID: 32601646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome.
    Enders G; Bäder U; Lindemann L; Schalasta G; Daiminger A
    Prenat Diagn; 2001 May; 21(5):362-77. PubMed ID: 11360277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TORCH Infections. Toxoplasmosis, Other (syphilis, varicella-zoster, parvovirus B19), Rubella, Cytomegalovirus (CMV), and Herpes infections.
    Stegmann BJ; Carey JC
    Curr Womens Health Rep; 2002 Aug; 2(4):253-8. PubMed ID: 12150751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China.
    Wang LC; Yan F; Ruan JX; Xiao Y; Yu Y
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):484. PubMed ID: 31818265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infection in pregnancy.
    Yinon Y; Farine D; Yudin MH; ;
    J Obstet Gynaecol Can; 2010 Apr; 32(4):348-354. PubMed ID: 20500943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive lesions of central nervous system in microcephalic fetuses with suspected congenital Zika virus syndrome.
    Sarno M; Aquino M; Pimentel K; Cabral R; Costa G; Bastos F; Brites C
    Ultrasound Obstet Gynecol; 2017 Dec; 50(6):717-722. PubMed ID: 27644020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of a positive TORCH and parvovirus B19 screening in pregnancies complicated by polyhydramnios.
    Pasquini L; Seravalli V; Sisti G; Battaglini C; Nepi F; Pelagalli R; Di Tommaso M
    Prenat Diagn; 2016 Mar; 36(3):290-3. PubMed ID: 26970557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TORCH infections in mothers as a cause of neonatal morbidity].
    Mladina N; Mehikić G; Pasić A
    Med Arh; 2000; 54(5-6):273-6. PubMed ID: 11219902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.